Search Results - "Ferreira, Valerie"

Refine Results
  1. 1

    Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy by Ferreira, Valerie, Twisk, Jaap, Kwikkers, Karin, Aronica, Eleonora, Brisson, Diane, Methot, Julie, Petry, Harald, Gaudet, Daniel

    Published in Human gene therapy (01-03-2014)
    “…Cellular immune responses to adeno-associated viral (AAV) vectors used for gene therapy have been linked to attenuated transgene expression and loss of…”
    Get more information
    Journal Article
  2. 2

    Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene Transfer by Pipe, Steven, Leebeek, Frank W.G., Ferreira, Valerie, Sawyer, Eileen K., Pasi, John

    “…As gene transfer with adeno-associated virus (AAV) vectors is starting to enter clinical practice, this review examines the impact of vector capsid choice in…”
    Get full text
    Journal Article
  3. 3

    Cell-Based Tracers as Trojan Horses for Image-Guided Surgery by Sier, Vincent Q, de Vries, Margreet R, van der Vorst, Joost R, Vahrmeijer, Alexander L, van Kooten, Cornelis, Cruz, Luis J, de Geus-Oei, Lioe-Fee, Ferreira, Valerie, Sier, Cornelis F M, Alves, Frauke, Muthana, Munitta

    “…Surgeons rely almost completely on their own vision and palpation to recognize affected tissues during surgery. Consequently, they are often unable to…”
    Get full text
    Journal Article
  4. 4

    Immunoadsorption enables successful rAAV5-mediated repeated hepatic gene delivery in nonhuman primates by Salas, David, Kwikkers, Karin L., Zabaleta, Nerea, Bazo, Andrea, Petry, Harald, van Deventer, Sander J., Aseguinolaza, Gloria Gonzalez, Ferreira, Valerie

    Published in Blood advances (10-09-2019)
    “…Adeno-associated virus (AAV)–based liver gene therapy has been shown to be clinically successful. However, the presence of circulating neutralizing antibodies…”
    Get full text
    Journal Article
  5. 5

    Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5 ch and AAV1 by Majowicz, Anna, Salas, David, Zabaleta, Nerea, Rodríguez-Garcia, Estefania, González-Aseguinolaza, Gloria, Petry, Harald, Ferreira, Valerie

    Published in Molecular therapy (02-08-2017)
    “…In the gene therapy field, re-administration of adeno-associated virus (AAV) is an important topic because a decrease in therapeutic protein expression might…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis by van der Marel, Sander, Majowicz, Anna, Kwikkers, Karin, van Logtenstein, Richard, te Velde, Anje A, De Groot, Anne S, Meijer, Sybren L, van Deventer, Sander J, Petry, Harald, Hommes, Daniel W, Ferreira, Valerie

    Published in World journal of gastroenterology : WJG (28-08-2012)
    “…AIM:To explore the anti-inflammatory potential of adeno-associated virus-mediated delivery of Tregitope 167 in an experimental colitis model.METHODS:The…”
    Get full text
    Journal Article
  8. 8

    Teaching tolerance: New approaches to enzyme replacement therapy for Pompe disease by Cousens, Leslie P., Mingozzi, Federico, van der Marel, Sander, Su, Yan, Garman, Richard, Ferreira, Valerie, Martin, William, Scott, David W., De Groot, Anne S

    Published in Human vaccines & immunotherapeutics (01-10-2012)
    “…Babies born with Pompe disease require life-long treatment with enzyme-replacement therapy (ERT). Despite the human origin of the therapy, recombinant human…”
    Get full text
    Journal Article
  9. 9

    Murine CD4⁺CD25⁻ cells activated in vitro with PMA/ionomycin and anti-CD3 acquire regulatory function and ameliorate experimental colitis in vivo by Majowicz, Anna, van der Marel, Sander, te Velde, Anje A, Meijer, Sybren L, Petry, Harald, van Deventer, Sander J, Ferreira, Valerie

    Published in BMC gastroenterology (03-12-2012)
    “…Induced regulatory T (iTreg) lymphocytes show promise for application in the treatment of allergic, autoimmune and inflammatory disorders. iTreg cells…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Current use of benzodiazepines in anxiety disorders by Cloos, Jean-Marc, Ferreira, Valérie

    Published in Current opinion in psychiatry (01-01-2009)
    “…PURPOSE OF REVIEWThe aim of this study is to provide a review of articles published between July 2007 and August 2008 on the current use and rationale of…”
    Get full text
    Journal Article
  12. 12

    Recombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and Patients by Gil-Farina, Irene, Fronza, Raffaele, Kaeppel, Christine, Lopez-Franco, Esperanza, Ferreira, Valerie, D'Avola, Delia, Benito, Alberto, Prieto, Jesus, Petry, Harald, Gonzalez-Aseguinolaza, Gloria, Schmidt, Manfred

    Published in Molecular therapy (01-06-2016)
    “…Recombinant adeno-associated viral vectors (rAAV) currently constitute a real therapeutic strategy for the sustained correction of diverse genetic conditions…”
    Get full text
    Journal Article
  13. 13

    VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis by Hawinkels, Lukas J.A.C, Zuidwijk, Kim, Verspaget, Hein W, de Jonge-Muller, Eveline S.M, Duijn, Wim van, Ferreira, Valérie, Fontijn, Ruud D, David, Guido, Hommes, Daniel W, Lamers, Cornelis B.H.W, Sier, Cornelis F.M

    Published in European journal of cancer (1990) (01-09-2008)
    “…Abstract Angiogenesis is crucial for the progression of colorectal carcinomas in which the bioavailability of Vascular Endothelial Growth Factor (VEGF) plays a…”
    Get full text
    Journal Article
  14. 14

    Gene and cell therapy based treatment strategies for inflammatory bowel diseases by van der Marel, Sander, Majowicz, Anna, van Deventer, Sander, Petry, Harald, Hommes, Daniel W, Ferreira, Valerie

    “…Inflammatory bowel diseases(IBD)are a group of chronic inflammatory disorders most commonly affecting young adults.Currently available therapies can result in…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside by Ferreira, Valerie, Petry, Harald, Salmon, Florence

    Published in Frontiers in immunology (2014)
    “…Alipogene tiparvovec (Glybera(®)) is an adeno-associated virus serotype 1 (AAV1)-based gene therapy that has been developed for the treatment of patients with…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial by Gaudet, D, Méthot, J, Déry, S, Brisson, D, Essiembre, C, Tremblay, G, Tremblay, K, de Wal, J, Twisk, J, van den Bulk, N, Sier-Ferreira, V, van Deventer, S

    Published in Gene therapy (01-04-2013)
    “…We describe the 2-year follow-up of an open-label trial (CT-AMT-011–01) of AAV1-LPL S447X gene therapy for lipoprotein lipase (LPL) deficiency (LPLD), an…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele by Carmeliet, Peter, Ferreira, Valérie, Breier, Georg, Pollefeyt, Saskia, Kieckens, Lena, Gertsenstein, Marina, Fahrig, Michaela, Vandenhoeck, Ann, Harpal, Kendraprasad, Eberhardt, Carmen, Declercq, Cathérine, Pawling, Judy, Moons, Lieve, Collen, Désiré, Risau, Werner, Nagy, Andras

    Published in Nature (London) (04-04-1996)
    “…The endothelial cell-specific vascular endothelial growth factor (VEGF) and its cellular receptors Flt-1 and Flk-1 have been implicated in the formation of the…”
    Get full text
    Journal Article